Saturday, October 31, 2026

DraftKings Stock Soars 32% In 21 Sessions: Is It Time To Buy?

ViaNews Editorial Team

February 9, 2024

DraftKings Stock Soars 32% In 21 Sessions: Is It Time To Buy?

(VIANEWS) - DraftKings (NASDAQ: DKNG) stock prices have surged 32.05% over the last 21 sessions, increasing from EUR32.95 on January 12th to EUR43.51 by 11:18 EST on Friday at 11:18. The stock experienced two consecutive sessions of gains with the NASDAQ index also increasing by 0.53% to EUR15,877.05. DraftKings' last close price stood at EUR42.81; 1.88% higher than its 52-week high of EUR42.02. These increases suggest positive prospects for DraftKings going forward.

About DraftKings

DraftKings is an industry leader in digital sports entertainment and gaming, providing online sports betting and casino gaming, daily fantasy sports media products, consumer products, sports betting software for retail sportsbooks as well as iGaming operators, digital collectibles marketplace, mainstream accessibility for NFT drops and secondary market transactions, collectibles ecommerce platform. Headquartered in Boston Massachusetts.

Yearly Analysis

Based on this information, DraftKings Inc. (DKNG) appears to be an exciting company with vast potential in the sports betting and gaming industries. Let's break down its key figures and provide an investment perspective. 1. Yearly Top and Bottom Values: At present, the stock is trading above its 52-week high of EUR42.02; this indicates a positive sentiment toward its performance and expectations among investors. 2. Anticipated Sales Growth: DraftKings' sales growth projection for this year is estimated at 64.1% - an impressive number that shows their rapid expansion and ability to meet an increased demand. Their projected sales growth projection for next year stands at 27.7% which still represents healthy levels of expansion. 3. Earnings Before Interest, Taxes, Depreciation and Amortization (EBITDA): DraftKings' EBITDA stands at -60.05 which indicates it is currently operating at a loss; however it's essential to remember that this company is investing heavily in growth and expansion which may incur more expenses in the short-term. DraftKings Inc. appears to be an attractive investment option for those who believe in the long-term potential of sports betting and gaming industries, particularly sports betting and gaming. Strong sales growth and bullish market sentiment indicate that DraftKings may offer strong potential returns; however, investors must keep in mind its negative EBITDA figure and potential risks related to investing heavily in growth at once. Prior to investing, it is vitally important to conduct thorough research and analysis, consider your investment goals and risk tolerance, and consult a financial advisor in order to ascertain whether DraftKings Inc. fits into your investment strategy.

Technical Analysis

DraftKings Inc (DKNG) has experienced an upswing in its stock price recently, reaching EUR47.30 at present compared to EUR36.53 over its 50-day moving average and EUR30.13 over its 200-day moving average respectively. DraftKings' last reported volume was 577,7558; 51.3% lower than its average volume of 1,186,5200 indicating potential buyers could be absent and impact the stock price stability. The stock's volatility has been relatively high, with an average intraday variation over the last week of 1.14%, 2.08% in one month and 1.85% over three quarters - an indication of its price fluctuation within short timeframes. DraftKings' stock has reached oversold conditions (=20), suggesting it may be an ideal time for investors to acquire it. But those considering investing should do so with caution as prices can be affected by numerous external influences and can change rapidly.

Quarter Analysis

DraftKings Inc. (DKNG) has shown remarkable sales and revenue growth over its most recent quarter and subsequent one, reporting an astounding sales expansion rate of 45-71% and 34-7 % respectively. Estimates for growth estimates in both quarters are at 115.1% and 62.1%, respectively. Furthermore, Year-on-Year Quarterly Revenue Growth was robust at 57.4% for total twelve month trailing revenue of 3.29 billion. Investment OutlookDue to its strong growth trajectory, DraftKings stock could provide investors seeking exposure to fast-growing sports betting and iGaming industries with an investment opportunity that offers good diversification benefits. Investors should carefully examine a company's finances, valuation, and regulatory risks prior to making investment decisions. Furthermore, investors should monitor its ability to continue its current growth trajectory while expanding into new markets while managing costs effectively. DraftKings' growth prospects could be limited by the current COVID-19 pandemic and its effect on sports events and betting activities, however. Overall, its investment outlook appears positive given its potential growth and strong financials - however investors should perform due diligence before making any definitive investment decisions.

Equity Analysis

DraftKings' Earnings Per Share (EPS) over the past twelve months stands at EUR-2.17, meaning they did not generate a profit over this time frame. A negative EPS indicates poor financial health for this business and can indicate underperformance and potentially significant challenges ahead. Return on Equity (ROE) for the twelve trailing months was negative 89.44%, suggesting that shareholders have not seen sufficient profits generated and equity utilized effectively by their business. A negative ROE indicates poor financial health in an organization. Investors should exercise extreme caution when considering investing in companies with negative EPS and ROE figures, as these financial metrics could indicate they're struggling financially and not performing as planned. Before making any definitive investment decisions, further research and analysis must be completed on each company to understand its financial status and potential growth opportunities.

More news about DraftKings (DKNG).

ViaNews Editorial Team

Via News Editorial Team delivers comprehensive financial news coverage and market analysis from journalists around the world. Our team specializes in data journalism and in-depth reporting on stock markets, business developments, and economic trends.

What we know · the intelligence behind this page
Live from the substrate
What we're seeing
ESMO 2026 Oncology Catalyst Cluster: Ivonescimab's PDUFA Date and Small-Cap Biotech Delistings
ESMO 2026 (Oct 22-24) concentrates a wave of oncology readouts. Summit's ivonescimab (10 presentations, positive HARMONi-GI1 OS, new EA2251 Phase II/III with ECOG-ACRIN) leads, ahead of its FDA PDUFA date of 2026-11-14, and Daiichi Sankyo's DXd ADC platform (REJOICE-Ovarian, DESTINY-Lung04, TUXEDO-3) follows. At the other end of the capital-markets spectrum, micro-cap Spago Nanomedical is moving to delist from Nasdaq First North (board resolution Oct 22, EGM Nov 19, application Jan 2027). Pivotal data and regulatory milestones are rewarding well-funded late-stage players, while cash-constrained early-stage developers are exiting public markets.
Our read on the data ›
Signals we're tracking
EPKINLY Regulatory-Clinical Success Cascade
High probability of expanded label indications, additional combination approvals, and competitive positioning strength in follicular lymphoma market. Predicts positive commercial uptake and potential accelerated review for related indications.
Patterns we're watching ›
Where sources disagree
Ford Motor Company
Both facts give cash for Ford Motor Company at the same point in time (2025-12-31; FY 2025 year-end and Q4 2025 year-end are the same date). Both are labelled USD, but the values are 23,356,000,000 and 23.356, which cannot both be true in USD. The two numbers agree once the second is read as billions (23.356 bn = 23,356,000,000), so the economic content is consistent and the conflict is a unit/scale error in the Q4 2025 record. The period is not the reason for the conflict: a Q4 and an FY figure at the same year-end date should match.
We flag conflicts openly ›
Recently verified
✓ Checked against the original source
4,995
facts traced to their source — and we flag the ones that don't hold up.
101 entities tracked4,995 facts checked against source5,525 source documents archived
Query this data → isubstrate.com